Is Indo US Bio-Tech overvalued or undervalued?
As of November 10, 2025, Indo US Bio-Tech is considered an attractive investment due to its undervaluation compared to peers, with a PE ratio of 14.64, a strong ROE of 22.66%, and significant growth potential, despite recent stock performance lagging behind the Sensex.
As of 10 November 2025, the valuation grade for Indo US Bio-Tech has moved from fair to attractive, indicating a more favorable outlook for the company. The analysis suggests that the company is undervalued, especially when compared to its peers. Key ratios include a PE ratio of 14.64, an EV to EBIT of 14.03, and a PEG ratio of 0.15, which highlights significant growth potential relative to its price.In comparison to peers, Indo US Bio-Tech's PE ratio is significantly lower than Jain Irrigation's 58.41 and Krishival Foods' 82.28, both of which are categorized as very expensive. Additionally, the company's ROE stands at a robust 22.66%, further supporting its attractive valuation. Despite recent stock performance lagging behind the Sensex, particularly in the year-to-date return of -58.76% versus the Sensex's 6.91%, the underlying fundamentals suggest that Indo US Bio-Tech presents a compelling investment opportunity at its current price of 129.90.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
